Nir Sassi is Chief Financial Officer of Indaptus Therapeutics, Inc.. Currently has a direct ownership of 26,758 shares of INDP, which is worth approximately $67,162. The most recent transaction as insider was on Dec 22, 2025, when has been sold 26,758 shares (Common Stock) at a price of $2.03 per share, resulting in proceeds of $54,318. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.8K
n/a 3M change
n/a 12M change
Total Value Held $67,162

Nir Sassi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 22 2025
BUY
Grant, award, or other acquisition
$54,318 $2.03 p/Share
26,758 Added 50.0%
26,758 Common Stock
NS

Nir Sassi

Chief Financial Officer
New York, NY

Track Institutional and Insider Activities on INDP

Follow Indaptus Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INDP shares.

Notify only if

Insider Trading

Get notified when an Indaptus Therapeutics, Inc. insider buys or sells INDP shares.

Notify only if

News

Receive news related to Indaptus Therapeutics, Inc.

Track Activities on INDP